Addex Therapeutics Ltd (ADXN) — Cash Flow Reinvestment Rate

Latest as of December 2020: 0.07x

Addex Therapeutics Ltd (ADXN) has a Cash Flow Reinvestment Rate of 0.07x as of December 2020, reinvesting CHF49.23K (capex CHF48.09K plus investments CHF1.15K) from operating cash flow of CHF704.85K. See Addex Therapeutics Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.07x

(Capex + Investments) / Operating CF

Total Reinvested

CHF49.23K

Capex + Investments

Operating Cash Flow

CHF704.85K

CHF

Capital Expenditures

CHF48.09K

CHF

Addex Therapeutics Ltd Cash Flow Reinvestment Rate (2018–2018)

Historical reinvestment intensity for Addex Therapeutics Ltd across 1 annual periods. For the full cash flow conversion analysis, see ADXN cash flow metrics.

Annual Cash Flow Reinvestment Rate for Addex Therapeutics Ltd (2018–2018)

Year-by-year capital reinvestment analysis for Addex Therapeutics Ltd. See ADXN free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (CHF)	Operating CF	Capex	YoY Change
2018	0.03x	CHF56.37K	CHF1.75 Million	CHF9.05K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow